CN102462765A - Medicine composition for treating eczema - Google Patents
Medicine composition for treating eczema Download PDFInfo
- Publication number
- CN102462765A CN102462765A CN2010105587502A CN201010558750A CN102462765A CN 102462765 A CN102462765 A CN 102462765A CN 2010105587502 A CN2010105587502 A CN 2010105587502A CN 201010558750 A CN201010558750 A CN 201010558750A CN 102462765 A CN102462765 A CN 102462765A
- Authority
- CN
- China
- Prior art keywords
- ointment
- medicine composition
- parts
- lithargyrum
- borneolum syntheticum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention provides a medicine composition for treating eczema, which is characterized by being an ointment prepared from the following raw materials in proportion by weight: 8 to 10 parts of lead monoxide, 4 to 6 parts of phellodendron, 1.5 to 3 parts of borneol and 1 to 3 parts of benne oil. When the medicine composition is prepared, the raw lead monoxide, the phellodendron and the borneol are ground into fine powder; and then, the benne oil is added for preparing the ointment to obtain the medicine composition. When the ointment is in use, about 5g of the ointment is taken each time, is uniformly applied to an afflicted part once a day, and continuously used for 6 to 7 days. The medicine composition provided by the invention has the advantages of simple compatibility, reasonable dosage, convenience in utilization and obvious treating effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of pharmaceutical composition of treating eczema.
Background technology
Eczema is a kind of acute, subacute or chronically inflamed, and the epidermis that is caused by multiple internal and external factor and the inflammatory skin of high dermis are sick.Its clinical manifestation has characteristics such as symmetry, exudative, pruritus property, pleomorphism and recurrent.Also be a kind of allergic inflammation dermatoses with the erythra multiformity, be symmetrically distributed, violent pruritus shows effect, is prone to develop into the chronic characteristic that is repeatedly.Can betide any position of any age, but recur or aggravate the winter of being everlasting the tendency of oozing out arranged any season, the chronic course of disease is prone to outbreak repeatedly
Summary of the invention
Technical problem to be solved by this invention is the deficiency to prior art, and a kind of pharmaceutical composition of the new treatment eczema that compatibility is reasonable, therapeutic effect is good is provided.
Technical problem to be solved by this invention is to realize through following technical scheme.The present invention is a kind of pharmaceutical composition of treating eczema, is characterized in: it is the ointment of being processed by following materials of weight proportions,
The Lithargyrum 8～10; Cortex Phellodendri 4～6;
Borneolum Syntheticum 1.5～3; Oleum Sesami 1～3.
During preparation, will give birth to Lithargyrum, Cortex Phellodendri, Borneolum Syntheticum pulverization, and add Oleum Sesami then and process ointment, promptly get.
Technical problem to be solved by this invention can also further realize through following technical scheme.The pharmaceutical composition of above-described treatment eczema is characterized in: the weight proportion of each raw material is,
The Lithargyrum 9; Cortex Phellodendri 4.5;
Borneolum Syntheticum 2.5; Oleum Sesami 2.
During use, get about ointment 5 grams of the present invention at every turn, evenly put on the skin, once a day, used continuously 6-7 days in the affected part.Compared with prior art, the simple resultant of compatibility of the present invention, easy to use, significant curative effect is arranged.
The specific embodiment
Below further describe concrete technical scheme of the present invention,, and do not constitute restriction its right so that those skilled in the art understands the present invention further.
Embodiment 1.A kind of pharmaceutical composition of treating eczema, it is the ointment of being processed by following materials of weight proportions,
The Lithargyrum 8; Cortex Phellodendri 4;
Borneolum Syntheticum 1.5; Oleum Sesami 1.
During preparation, will give birth to Lithargyrum, Cortex Phellodendri, Borneolum Syntheticum pulverization, and add Oleum Sesami then and process ointment, promptly get.
Embodiment 2.A kind of pharmaceutical composition of treating eczema, it is the ointment of being processed by following materials of weight proportions,
The Lithargyrum 9; Cortex Phellodendri 4.5;
Borneolum Syntheticum 2.5; Oleum Sesami 2.
Embodiment 3.A kind of pharmaceutical composition of treating eczema, it is the ointment of being processed by following materials of weight proportions,
The Lithargyrum 10; Cortex Phellodendri 6;
Borneolum Syntheticum 3; Oleum Sesami 3.
Claims (2)
1. pharmaceutical composition of treating eczema, it is characterized in that: it is the ointment of being processed by following materials of weight proportions,
The Lithargyrum 8～10; Cortex Phellodendri 4～6;
Borneolum Syntheticum 1.5～3; Oleum Sesami 1～3.
During preparation, will give birth to Lithargyrum, Cortex Phellodendri, Borneolum Syntheticum pulverization, and add Oleum Sesami then and process ointment, promptly get.
2. the pharmaceutical composition of treatment eczema according to claim 1 is characterized in that: the weight proportion of each raw material is,
The Lithargyrum 9; Cortex Phellodendri 4.5;
Borneolum Syntheticum 2.5; Oleum Sesami 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105587502A CN102462765A (en) | 2010-11-18 | 2010-11-18 | Medicine composition for treating eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105587502A CN102462765A (en) | 2010-11-18 | 2010-11-18 | Medicine composition for treating eczema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102462765A true CN102462765A (en) | 2012-05-23 |
Family
ID=46067073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105587502A Pending CN102462765A (en) | 2010-11-18 | 2010-11-18 | Medicine composition for treating eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102462765A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908440A (en) * | 2012-11-10 | 2013-02-06 | 陈丽芳 | Medicine for treating eczema |
| CN103417700A (en) * | 2013-08-22 | 2013-12-04 | 王爱枝 | Drug for treatment of eczema and preparation method thereof |
-
2010
- 2010-11-18 CN CN2010105587502A patent/CN102462765A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908440A (en) * | 2012-11-10 | 2013-02-06 | 陈丽芳 | Medicine for treating eczema |
| CN103417700A (en) * | 2013-08-22 | 2013-12-04 | 王爱枝 | Drug for treatment of eczema and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872241A (en) | Traditional Chinese medicinal composition for treating inflammatory dermatosis and preparation thereof | |
| CN102462765A (en) | Medicine composition for treating eczema | |
| JP2014530223A5 (en) | ||
| CN103417572A (en) | External medicine for treating beriberi | |
| CN105998064B (en) | A kind of application of active carbon nanoparticles colloidal sol in the drug of preparation treatment eczema | |
| CN102920932A (en) | Medicinal composition for treating eczema | |
| CN102114068B (en) | Medicament for external application for treating scabies and eczema and preparation method thereof | |
| CN102579789B (en) | Medicine for treating eczema | |
| CN101757026B (en) | Dermatitis curative | |
| CN101785791A (en) | Traditional Chinese medicine for infantile eczema treatment | |
| CN104510865A (en) | Traditional Chinese medicine powder for treating bedsore | |
| CN102793797B (en) | Medicine for treating tinea manus | |
| CN102908400A (en) | Traditional Chinese medicine for treating skin eczemas | |
| CN105596364A (en) | Skin disease external application drug, preparation method and uses thereof | |
| CN102488128B (en) | Food composition having function of assisting in depressing blood-fat and preparation method thereof | |
| CN103893376A (en) | Traditional Chinese medicine composition for treating skin eczema and bleb and preparation method thereof | |
| CN102988963A (en) | Clinical research formula of diabetes mellitus | |
| CN103948628A (en) | Emulsion for treating scytitis | |
| CN102784291B (en) | A kind of liniment for the treatment of toothache with asthenic yin | |
| CN102049023A (en) | Traditional Chinese medicine formula for treating vaginal discharge diseases | |
| CN102283982B (en) | Medicinal composition for treating skin diseases | |
| CN109700868A (en) | A kind of instant particles as Chinese medicine and preparation method thereof for treating psoriasis | |
| CN103550301B (en) | A kind of preparation being used for the treatment of bromhidrosis | |
| CN102743483A (en) | Medicine for treating eczema | |
| CN102772544B (en) | A kind of cream drug for the treatment of scrotum scabies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120523 |